tbuckley/cabot-search huggingface dataset:
Negative Results
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
AMEBIC LIVER ABSCESS
Authors: M ZUCKERBROD, J LITWINS
Journal: Annals of Internal Medicine (1948)

Article1 April 1948AMEBIC LIVER ABSCESSMORRIS ZUCKERBROD, JOSEPH LITWINS, F.A.C.P., FRANCIS T. ROGLIANO, DAVID JELLINGERMORRIS ZUCKERBRODSearch for more papers by this author, JOSEPH LITWINS, F.A.C.P.Search for more papers by this author, FRANCIS T. ROGLIANOSearch for more papers by this author, DAVID JELLINGERSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-28-4-798 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptAmebic abscess of the liver is the most important complication of amebiasis. It is not a rare condition. Its highest incidence is in the tropics and subtropics, but, while it is reputed to be rare in the temperate climates, there is evidence from autopsy records (Craig1) that it is also fairly common in the temperate zones, though often not recognized during life. With the return of so many soldiers and civilians from areas in which amebiasis is endemic and epidemic, amebic abscess of the liver and amebic hepatitis will be seen much more frequently in the temperate climates. The following...Bibliography1. CRAIG CF: Etiology, diagnosis and treatment of amebiasis, 1944, Williams and Wilkins Co., Baltimore, page 150. Google Scholar2. STRONGMUSGRAVE RPWE: 1900 Reports of Surgeon General U. S. A., Washington, D. C., page 250. Google Scholar3. CLARK HC: Distribution and complications of amebic lesions found in 186 postmortem examinations, Am. Jr. Trop. Med., 1925, v, 157. CrossrefGoogle Scholar4. OCHSNERDE BAKEY AM: Amebic hepatitis and hepatic abscess: analysis of 181 cases with review of literature, Surgery, 1943, xiii, 460, 612. Google Scholar5. TAO SM: Entamoeba histolytica infection in North China. Study of 1000 positive cases, Nat. Med. Jr. China (English language version), 1931, xvii, 412-434. Google Scholar6. OCHSNERDE BAKEY AM: Ibid. Google Scholar7. CRAIG CF: Ibid., page 157. Google Scholar8. ROGERS L: An amebic liver abscess; its pathology, prevention and cure, Trans. Med. Soc. London, 1923, xlv, 130. Google Scholar9. CRAIG CF: Ibid., page 305. Google Scholar10. THURSTON EO: Liver abscess, Lancet, 1924, ii, 1008-1010. CrossrefGoogle Scholar11. CRAIG CF: Ibid., page 307. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: *Received for publication April 30, 1946. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 April 1948Volume 28, Issue 4Page: 798-813KeywordsAbscessesLiver ePublished: 14 March 2020 Issue Published: 1 April 1948 PDF downloadLoading ...
The L-S Ratio
Authors: Charles R. Rosenfeld
Journal: JAMA (1974)

IN industrialized societies, the major cause of death during the first week of life is clinical hyaline membrane disease (CHMD), an entity that occurs primarily in premature infants. Simply stated, the condition consists of an inability to keep the alveoli from collapsing at the end of expiration, which leads to progressive ventilation-perfusion abnormalities, insufficient exchange of respiratory gases, and, finally, to cardiorespiratory collapse. The etiology is not fully understood, but evidence suggests that CHMD results from insufficient production of surface-active phospholipids, collectively referred to as<i>pulmonary surfactant</i>. These substances are probably produced and stored within the type II alveolar lining cells and are then "secreted" into the lumen where they coat the alveolar surface, decreasing surface tension at end-expiration, and thereby preventing alveolar collapse. Pulmonary surfactant is decreased in the lung of prematurely born fetuses and of those newborn infants who develop CHMD. As gestation progresses, increasing quantities can be
LYMPHATISM AS A FAMILY DISEASE.
Journal: JAMA (2006)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Salute to the clinical pathologists
Journal: JAMA (1971)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Scientific Program
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
"CHRISTIAN SCIENCE" FOLLY.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
NCCN NewsNew NCCN Pharmacy Updates Webinars LaunchedAccess NCCN Templates Within Your Electronic Health Record
Authors: Richard Fong, Laura Michaud
Journal: Journal of the National Comprehensive Cancer Network (2018)

New NCCN Pharmacy Updates Webinars LaunchedThe availability of new therapeutic options and emergence of novel therapies continues to dramatically impact the oncology landscape.The new NCCN Pharmacy Updates Webinar Series is designed for pharmacists, nurses, and other members of the oncology care team to review the clinical and patient considerations that influence how to effectively optimize management of patients with various cancer types.Featuring expert faculty from NCCN Member Institutions, the following schedule of webinars is aimed at providing clinicians with the latest advances in patient management in order to deliver optimal care: • Introduction to the NCCN Guidelines for Myeloproliferative Neoplasms and aComprehensive Review of the Use of JAK2 Inhibitors Friday, February
American Journal of Medicine, New York
Journal: JAMA (1970)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Vascular endothelial growth factor and von Willebrand factor levels: Clinical outcome in stage IV colorectal cancer
Authors: I. Gil-Bazo, J. Rodríguez, V. Catalán, V. Navarro, A. Chopitea, J. Espinós, A. Gúrpide, M. Santisteban, J. García-Foncillas, S. Martín-Algarra
Journal: Journal of Clinical Oncology (2004)

3754 Background: von Willebrand factor (vWf) is thought to mediate binding of tumor cells to platelets, favouring their spreading capacity. Platelets involved in tumor angiogenesis are capable of releasing vascular endothelial growth factor (VEGF). Levels of vWf and VEGF may correlate with cancer stage and predict clinical outcome. The aim of this study was to correlate vWf and VEGF levels in stage IV colorectal cancer (CRC) patients undergoing chemotherapy (CMT) with response to treatment and time to progression (TTP). Methods: 25 metastatic CRC patients attending the Department of Oncology of our institution were enrolled in the study. Blood samples were taken before and after fluoropirimidine-based CMT, and stored until further processing. vWf, VEGF, platelet count, carcinoembrionary antigen (CEA) and CA 19.9 were measured using standardised techniques. Tumor burden assessed by number of locations of disease was also considered. Patients received a median of 3 cycles of CMT (range: 2–10) between both blood samples. Results: After 3 cycles of CMT, 11 patients showed stable disease (SD), 8 had responded partially (PR) and 6 patients showed progression (P). After a median follow-up of 9 months, 18 of 25 patients showed P, and the median TTP was 8.6 months. The hazard ratio (HR) (and its 95% confidence interval [CI]) for progression associated to an increase in one standard deviation in baseline levels of VEGF was 6.68 (2.45 – 18.18; p<0.001). For change in one standard deviation in the difference between VEGF levels after CMT and VEGF baseline levels, the HR for progression (95% CI) was 3.37 (1.34 – 8.49; p=0.01). In addition, considering vWf levels after CMT and vWf baseline levels, the HR for progression (95% CI) was 2.95 (1.37 – 6.34; p=0.006). These results were adjusted for age, gender, ECOG performance status and baseline platelet count. Adjusted additionally for CEA, CA 19.9 and tumor burden, no significant changes were found. Conclusions: VEGF serum pre-CMT levels and the increase of VEGF serum and vWf plasma levels during CMT may predict response to treatment and TTP in stage IV CRC patients. Supported by a grant of Gobierno de Navarra (RN 19/2003). No significant financial relationships to disclose.
Adolescent Medicine
Authors: Michele D. Wilson
Journal: JAMA (1995)

During the past few decades, the health status of adolescents in this country has been declining. Major causes of morbidity and mortality during the second decade of life are behavioral and psychosocial rather than purely biomedical. Hence, the salient issues for adolescent health relate predominately to violence and injuries (intentional and unintentional), substance use, and the consequences of unprotected sexual activity: unintended pregnancies and sexually transmitted infections, including human immunodeficiency virus and acquired immunodeficiency syndrome. Despite increased attention, violence continues to cause major health problems for adolescents. Several large-scale surveys of adolescents underscore the extent of violence and its impact on adolescents' emotional health. In a telephone survey of a nationally representative sample of children and adolescents aged 10 to 16 years, one fourth of respondents reported having experienced an assault or abuse (victimization) in the previous year.<sup>1</sup>Victimization included assault by nonfamily or a family member, kidnapping, sexual
Genetic Nondiscrimination
Authors: Mike Mitka
Journal: JAMA (2007)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
This Week in &lt;EMPH&gt;JAMA&lt;/EMPH&gt;
Journal: JAMA (2006)

A Piece of My Mind" 'Dad, do I have leukemia?'This is a question I have not been trained to respond to during nearly 2 decades as a physician, nor during 16 years as a parent."From "The CBC." SEE PAGE 149 Medical News & PerspectivesResults from phase 3 clinical trials of targeted therapies for metastatic renal cell carcinoma may prompt changes in the standard of care for this disease.
Rilotumumab Extends PFS in Gastric Cancer
Journal: Cancer Discovery (2014)

Abstract Patients with gastric or esophagogastric cancer treated with combination chemotherapy and rilotumumab, an anti-HGF monoclonal antibody, had longer progression-free survival than patients treated with chemotherapy alone, according to results from a phase II clinical trial. The survival benefit was greatest in patients with MET-positive disease; a phase III trial testing the drug combination's effect on this patient population is now under way.
Treatment of the General Diseases of the Eye.
Journal: JAMA (1900)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
PATHOLOGY OF DREAMS.
Journal: JAMA (1907)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
HIV counseling and testing of pregnant women
Authors: K. A. Phillips
Journal: JAMA (1996)

<h3>To the Editor.</h3> —The Centers for Disease Control and Prevention (CDC) recommends that all pregnant women and women of childbearing age be counseled and encouraged to be voluntarily tested for the human immunodeficiency virus (HIV),<sup>1</sup>and California legally requires physicians to offer voluntary testing to all pregnant women.<sup>2</sup>Furthermore, the US Senate and House recently agreed on a bill that could require states to demonstrate that 95% of pregnant women get tested in order to receive Ryan White funds.<sup>3</sup> The debate over whether testing should be mandatory, routine without explicit consent, or voluntary makes it important to assess physicians' beliefs about these policies and whether guidelines are being followed. We conducted a survey to examine physicians' self-reported beliefs and practices about HIV testing (n=121). Herein we report results concerning HIV testing of pregnant women, using a subsample of physicians who provide care for pregnant women (n=61). We
Rupture of Cardiac Papillary Muscle
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal